United States Generic Drugs Market Research Report Forecast 2024

Posted by Bharat Book on June 19th, 2018

Bharat Book Bureau Provides the Trending Market Research Report on “United States Generic Drugs  Market, By Type & Companies 2024 ”under Life Science category. The report offers a collection of superior market research, market analysis, competitive intelligence and industry reports.

United States Generic Drugs Market is projected to exceed USD 210 Billion by 2024. United States Generic Drugs Market is so huge that nearly 80% of dispensing prescriptions accounts generic drugs. According to FDA in the United States 9 out of 10 prescriptions filled are for generic drugs. Most of the physicians and hospitals are now prescribing generic drugs than that of the brand-name drugs. Generic Drugs are those drugs which have same active component as patent drugs in same outline & equal amounts. Generic drugs are also called as Off-Label drugs.

The prime reason for the growth of United States Generic Drugs Market can be attributed to its pricing, on an average generic (Off-Label) drug is around 40-60% cheaper than those of Branded Drugs. However, this price of generic drug further declines, when various generic drug companies target a single approved drug, then market competition results in prices 85% less than the branded drugs. Also, increasing number of drug patent expirations, government initiatives and rising prevalence of chronic diseases are some other factors which are expected to propel the growth of United States Generic Drugs Market in the near future.

Request a free sample copy of Generic Drugs Market Report @
https://www.bharatbook.com/MarketReports/Sample/Reports/1123452

“United States Generic Drugs Market, By Therapeutic Application [Central Nervous System (CNS), Cardiovascular, Dermatology, Genitourinary (GU)/Harmonal Drugs, Respiratory, Anti-infective, Oncology & Others], Companies (Teva, Mylan N.V., Sandoz, Endo Pharmaceuticals, Lupin Limited, Dr Reddy’s, Sun Pharma, & Others)” provides a complete analysis of US Generic Drugs Market.

Therapeutic Application – Oncology Generic Drug Market is likely to witness a Significant Growth during the Forecast Period

The report studies the market of the following Therapeutic Application segments: Central Nervous System (CNS), Cardiovascular, Dermatology, Genitourinary (GU) / Harmonal Drugs, Respiratory, Anti-infective, Oncology & Others. Central Nervous System (CNS), Cardiovascular, Respiratory and Oncology are some of the segments that will attract the attention of generic drugs market participants.

All companies in this report has been covered with following view points

1. Company Strategy
2. Sales

Companies Analysis

Teva, Mylan, Sandoz, Endo Pharmaceuticals, Lupin Limited, Dr Reddy’s, Sun Pharma are some of the top companies operating in the United States Generic Drug Market; which has been studied thoroughly in the report.

By Therapeutic Application:

• Central Nervous System (CNS)
• Cardiovascular
• Dermatology
• Genitourinary (GU)/Harmonal Drugs
• Respiratory
• Anti-infective
• Oncology
• Others

Key Companies Covered in the Report:

• Teva
• Mylan N.V.
• Sandoz
• Endo Pharmaceuticals
• Lupin Limited
• Dr Reddy’s
• Sun Pharma
• Others

Browse our full report with Table of Contents :
https://www.bharatbook.com/MarketReports/United-States-Generic-Drugs-Market-By-Therapeutic-Application-CNS-Cardiovascular-Dermatology-Oncology-GU-Respiratory-Ant/1123452

About Bharat Book Bureau: 
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology. 

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com

Follow us on : Twitter, Facebook, LinkedIn, Google Plus